Latest Period
Q4 2025
Security Snapshot
Envoy Medical, Inc. - Class A Common Stock (COCHW) Institutional Ownership
CUSIP: 29415V117
13F Institutional Holders and Ownership History from Q3 2023 to Q4 2025
Institutions Reporting
33
Shares (Excl. Options)
5,611,972
Price
$0.04
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.
- Type / Class
- Equity / Class A Common Stock
- Symbol
- COCHW on Nasdaq
- Shares outstanding
- 23,423,361
- Price per share
- $0.05
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 5,611,972
- Total reported value
- $225,941
- % of total 13F portfolios
- 0%
- Share change
- -213,647
- Value change
- -$7,746
- Number of holders
- 33
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- COCHW - Envoy Medical, Inc. - Class A Common Stock is tracked under CUSIP 29415V117.
- 33 institutions reported positions in Q4 2025.
- 3 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 35 to 33 between Q3 2025 and Q4 2025.
- Reported value moved from $318,752 to $225,941.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 33 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP 29415V117?
CUSIP 29415V117 identifies COCHW - Envoy Medical, Inc. - Class A Common Stock in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Continue With The Right Next Step
- Latest 13F filings - identify new institutional portfolio moves.
- Latest Schedule 13D/13G reports - cross-check beneficial ownership events.
- All institutional ownership pages - compare nearby CUSIPs and holder concentration.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 29415V117:
Significant Owners of Envoy Medical, Inc. - Class A Common Stock (COCHW) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Alta Partners LLC | 8.3% | $97,207 | 1,944,139 | Alta Partners LLC | 20 Aug 2025 | |||
| ARISTEIA CAPITAL, L.L.C. | 4.7% | $53,046 | 1,060,922 | Aristeia Capital, L.L.C. | 31 Mar 2025 | |||
| Walleye Capital LLC | 2.7% | $28,337 | 566,735 | Walleye Capital LLC | 31 Dec 2024 |
As of 31 Dec 2025, 33 institutional investors reported holding 5,611,972 shares of Envoy Medical, Inc. - Class A Common Stock (COCHW). This represents 24% of the company’s total 23,423,361 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of Envoy Medical, Inc. - Class A Common Stock (COCHW) together control 23% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| ARISTEIA CAPITAL, L.L.C. | 4.9% | 1,143,978 | +7.8% | 0% | $49,534 |
| TORONTO DOMINION BANK | 2.3% | 534,928 | 0% | 0% | $20,862 |
| Sandia Investment Management LP | 2.2% | 514,702 | -13% | 0.05% | $20,022 |
| Clear Street Group Inc. | 1.3% | 301,216 | -30% | 0% | $11,717 |
| Polar Asset Management Partners Inc. | 1.3% | 297,100 | 0% | 0% | $11,884 |
| BNP PARIBAS FINANCIAL MARKETS | 1.2% | 283,333 | 0% | 0% | $11,022 |
| Bracebridge Capital, LLC | 1.1% | 262,156 | 0% | 0% | $10,198 |
| Diametric Capital, LP | 1.1% | 258,328 | 0% | 0% | $10,048 |
| JANE STREET GROUP, LLC | 0.89% | 208,166 | 0% | 0% | $8,097 |
| Sculptor Capital LP | 0.78% | 182,137 | 0% | 0% | $7,887 |
| WHITEBOX ADVISORS LLC | 0.74% | 174,000 | 0% | 0% | $6,769 |
| MOORE CAPITAL MANAGEMENT, LP | 0.71% | 166,666 | 0% | 0% | $6,483 |
| Vestcor Inc | 0.71% | 166,666 | 0% | 0% | $7,000 |
| Q Global Advisors, LLC | 0.55% | 129,120 | 0% | 0% | $5,000 |
| GOLDMAN SACHS GROUP INC | 0.53% | 125,039 | 0% | 0% | $4,864 |
| D. E. Shaw & Co., Inc. | 0.48% | 113,431 | 0% | 0% | $4,378 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.48% | 111,272 | +74% | 0% | $4,328 |
| DUPONT CAPITAL MANAGEMENT CORP | 0.43% | 100,000 | 0% | 0% | $4,330 |
| Calamos Advisors LLC | 0.43% | 100,000 | 0% | 0% | $4,330 |
| Silver Rock Financial LP | 0.35% | 81,975 | 0% | 0.01% | $3,189 |
| Empyrean Capital Partners, LP | 0.32% | 75,000 | 0% | 0% | $2,918 |
| WOLVERINE ASSET MANAGEMENT LLC | 0.23% | 54,646 | -16% | 0% | $2,126 |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 0.21% | 50,000 | 0% | 0% | $1,945 |
| Marathon Trading Investment Management LLC | 0.14% | 32,888 | 0% | 0% | $1,279 |
| Ancora Advisors LLC | 0.1% | 24,522 | 0% | 0% | $954 |
Institutional Holders of Envoy Medical, Inc. - Class A Common Stock (COCHW) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 5,611,972 | $225,941 | -$7,746 | $0.04 | 33 |
| 2025 Q3 | 5,954,207 | $318,752 | +$62,549 | $0.04 | 35 |
| 2025 Q2 | 6,177,812 | $239,263 | +$10,079 | $0.04 | 34 |
| 2025 Q1 | 5,909,658 | $191,582 | -$10,286 | $0.03 | 35 |
| 2024 Q4 | 6,719,747 | $300,969 | -$7,415 | $0.05 | 38 |
| 2024 Q3 | 6,820,578 | $542,684 | -$16,365 | $0.08 | 40 |
| 2024 Q2 | 7,162,392 | $376,945 | -$42,786 | $0.05 | 43 |
| 2024 Q1 | 7,821,063 | $829,119 | -$262,724 | $0.11 | 45 |
| 2023 Q4 | 7,058,656 | $495,899 | +$485,698 | $0.02 | 48 |
| 2023 Q3 | 511,532 | $45,470 | +$45,470 | $0.07 | 2 |